VEGFB and neoplasm: Other studies have found that miR-345, which was upregulated in days 14–30 post-delivery in the present analysis, may have a role as a tumor suppressor and can inhibit adipocyte differentiation via targeting of VEGF-B (vascular endothelial growth factor B) in vitro74.